FDA approves new Covid shots with limits on who can get them under RFK Jr.
Financial News
CNBC

FDA approves new Covid shots with limits on who can get them under RFK Jr.

Why This Matters

It's unclear how easily patients without high risk factors will be able to get a Covid shot, and whether insurance plans will still cover them.

August 27, 2025
06:22 PM
4 min read
AI Enhanced

Pfizer's Covid vaccine Comirnaty, seen at a CVS Pharmacy in Eagle Rock, California, Sept.

14, 2023.Irfan Khan | Los Angeles Times | Getty ImagesThe Food and Drug Administration on Wednesday apved the round of Covid vaccines in the U.S., but set new limits on who can get them.The agency its broader authorization of the shots, only ing them for people at higher risk of severe illness.

That includes those 65 and up and younger adults with at least one underlying condition that puts them at higher risk.The move could complicate access to the shots for millions of Americans, and raises questions whether insurance plans will still cover them for healthy adults."The emergency use authorizations for Covid vaccines, once used to justify broad mandates on the general public during the Biden administration, are now rescinded," Health and Human Services Secretary Robert F.

Kennedy Jr. said in a post on X."The American people demanded science, safety, and common sense," he said.

"This framework ders all three."It s several efforts by Kennedy, a minent vaccine skeptic, to change immunizations in the U.S. The new limited authorizations are a break from U.S.

vaccine policy in previous years, which an annual Covid shot for all Americans 6 months and up.A key panel of vaccine advisors to the Centers for Disease Control and Prevention must vote to recommend the Covid shots.

But Kennedy earlier this year gutted that panel and named new members, some of whom are widely known vaccine critics.In the post, Kennedy said the shots are available for all patients who choose them after consulting with their doctors.

But it's un how easily patients without high risk factors will be able to get a Covid vaccine.Kennedy said the FDA has authorized Moderna's shot for those 6 months and up, Pfizer's vaccine for people ages 5 and up and Novavax's jab for those ages 12 and up, but for those specifically at higher risk of getting severely sick from the virus.Adults ages 65 and up are at higher risk of severe Covid, and so are younger adults who are immunocommised or have underlying medication conditions such as cancer, obesity, diabetes, chronic kidney disease and heart diseases, according to the CDC's website.The end of the so-called emergency use authorizations means that Pfizer's shot is no longer ed for children ages 6 months to 4 years.

It comes after Pfizer in August said it has requested that the FDA keep that authorization in place for the upcoming fall and winter season.In a release, Pfizer confirmed that the FDA had ed its d Covid shot for use in adults 65 and above and those ages five through 64 with at least one underlying condition that puts them at high risk for severe illness.

The company will begin shipping the shot immediately, and it will be available in pharmacies, hospitals and clinics nationwide "in the coming days."In a separate release, Moderna also confirmed that its d Covid shot is apved for those 65 and up and people 6 months through 64 years of age who are at higher risk of severe illness.

The company added that its new, next-generation Covid vaccine is apved for older adults and high-risk patients ages 12 through 64.

Moderna said it expects the shots to be available in the coming days.s of Pfizer and Moderna were trading slightly higher Wednesday afternoon, while Novavax s dipped.In May, the CDC dropped the recommendation that pregnant women and healthy children receive Covid shots.

But the American Academy of Pediatrics diverged from the agency earlier this month, recommending Covid shots for children between 6 months and 2 years old.The American College of Obstetricians and Gynecologists also advised pregnant women to get the Covid vaccine to tect themselves and their infants, who cannot be immunized until they are 6 months old.

FinancialBooklet Analysis

AI-powered insights based on this specific article

Key Insights

  • This development warrants monitoring for potential sector-wide implications
  • Similar companies may face comparable challenges or opportunities
  • Market participants should assess the broader industry context

Questions to Consider

  • What broader implications might this have for the industry or sector?
  • How could this development affect similar companies or business models?
  • What market or economic factors might be driving this development?

Stay Ahead of the Market

Get weekly insights into market shifts, investment opportunities, and financial analysis delivered to your inbox.

No spam, unsubscribe anytime